Forensic Particulate Investigations: Navigating Quality Control Obstacles
When Quality Control (QC) identifies an...
PDA Week 2026 Recap: Advancing Particulate Science, CCI Strategy, and Regulatory Readiness
As PDA Week 2026 comes to...
Live at PDA Week 2026: Visit Gateway Analytical at the Aptar Pharma Exhibit
PDA WEEK – DENVER, CO –...
Gateway Analytical and Aptar Pharma Prepare to Showcase Integrated Drug Delivery & Analytical Solutions at PDA Week 2026
PDA WEEK – DENVER, CO –...
Gateway Analytical Prepares for PDA Week 2026: Let’s Talk Particulates, CCI, and 2026 Regulatory Readiness!
Are you attending PDA Week 2026,...
Forensic Particulate Investigations: Navigating Quality Control Obstacles
When Quality Control (QC) identifies an...
Closing the USP <1790> Gap: Demonstrating Inspection Adequacy for DIPs
As we face the new regulatory...
The Gateway Analytical Journal – Monthly Roundtable – Issue 01 // January 2026
Welcome to the Gateway Analytical Monthly...
Beyond Compliance: Navigating the Future of USP <382> and <661>
With the 2025 regulatory deadlines now...
USP <382> Is Now in Effect. Here’s What Your Team Needs to Do Next.
As of December 1, 2025, USP...